Mesoblast (MESO) Other Non Operating Income (2016 - 2025)
Mesoblast recorded quarterly Other Non Operating Income of -$311000.0 in Q4 2025, down 150.49% quarter-over-quarter from $616000.0 in Q2 2025.
Mesoblast's Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$311000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income changed N/A year-over-year to -$311000.0; the TTM figure through Dec 2025 stood at -$13000.0 (changed N/A YoY), while the FY2025 annual figure was $616000.0, up 487.42% from the prior year.
- Other Non Operating Income came in at -$311000.0 for Q4 2025 at Mesoblast, down from $616000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $986000.0 in Q1 2021 to a low of -$504000.0 in Q3 2022.
- A 5-year average of $83071.4 and a median of -$51500.0 in 2021 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income slumped 665.0% in 2021 and surged 1830.0% in 2023, its largest moves.
- Mesoblast's Other Non Operating Income stood at -$227000.0 in 2021, then jumped by 210.57% to $251000.0 in 2022, then sank by 163.35% to -$159000.0 in 2023, then changed by 0.0% to -$159000.0 in 2024, then tumbled by 95.6% to -$311000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$311000.0, $616000.0, and -$159000.0 for Q4 2025, Q2 2025, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -311,000.00 |
| Jun 30, 2025 | 616,000.00 |
| Jun 30, 2024 | -159,000.00 |
| Dec 31, 2023 | -159,000.00 |
| Jun 30, 2023 | 193,000.00 |
| Mar 31, 2023 | 363,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | -504,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 336,000.00 |
| Dec 31, 2021 | -227,000.00 |
| Sep 30, 2021 | -119,000.00 |
| Jun 30, 2021 | -113,000.00 |
| Mar 31, 2021 | 986,000.00 |
| Dec 31, 2020 | -417,000.00 |
| Sep 30, 2020 | 82,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Mar 31, 2020 | -442,000.00 |
| Dec 31, 2019 | -375,000.00 |
| Sep 30, 2019 | 232,000.00 |
| Jun 30, 2019 | -175,000.00 |
| Mar 31, 2019 | -8,000.00 |
| Dec 31, 2018 | -179,000.00 |
| Sep 30, 2018 | 10,000.00 |
| Jun 30, 2018 | -192,000.00 |
| Mar 31, 2018 | 289,000.00 |
| Dec 31, 2017 | 106,000.00 |
| Sep 30, 2017 | -93,000.00 |
| Mar 31, 2017 | 10,000.00 |
| Dec 31, 2016 | 10,000.00 |
| Sep 30, 2016 | 10,000.00 |